NHL Announces 2024-25 Salary Cap Range - Bleacher Nation
The Blackhawks still need to spend to the get to the NHL's salary floor for the coming season.
Source: bleachernation.com
📰 Upper Limit News
Upper Limit News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Upper Limit. Real-time updates on events, politics, business and more.
Travere Therapeutics Reports First Quarter 2024 Financial Results
FDA grants Priority Review for sNDA to convert FILSPARI® from accelerated approval to full approval for the treatment of IgAN in the U.S.; PDUFA target action date of September 5, 2024 Received 511...
Source: marketscreener.com
Komatsu : Announcement Concerning Revision of Performance-Linked Stock-Based Remuneration System
Announcement Concerning Revision of Performance-Linked Stock-Based Remuneration System Apr. 26, 2024 Komatsu Ltd. hereby...
Affiliate Company Directors Requirements For Beneficiaries Sustainability Promotion Division Shareholders Meetings Of Subject Companies Compensation Advisory Committee Corporate Communications Department
Source: marketscreener.com
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
First non-immunosuppressive therapy for the treatment of IgA nephropathy approved in Europe Conditional marketing authorization is based on statistically significant and clinically meaningful...
New Zealand Emmanuelle Lecomte Brisset Thomas Hutter Deric Dube University Hospital European Commission
Source: marketscreener.com
Travere Therapeutics to Present Abstracts on FILSPARI® (sparsentan) in IgA Nephropathy at World Congress of Nephrology and the American Nephrology Nurses Association
Upcoming data presentations underscore the potential for FILSPARI to become a foundational treatment for IgAN and Travere’s leadership and commitment to innovation in rare kidney disease SAN DIEGO,...
United States Buenos Aires Distrito Federal Jula Inrig Exchange Commission American Nephrology Nurses Association
Source: marketscreener.com
Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)
Submission is based on 2-year confirmatory results from the Phase 3 PROTECT Study in which FILSPARI demonstrated a significant reduction in proteinuria, preservation of kidney function and a generally...
Deric Dube Travere Therapeutics Inc Drug Administration European Commission European Union European Medicines Agency
Source: marketscreener.com
Nebraska bill would cap expensive prescription drug costs
Sen. Carol Blood says with the amount of money pharmaceutical companies rake in, they can afford to negotiate with Nebraska.
Source: ketv.com
Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
15.02.2024 - Received 459 new patient start forms (PSFs) for FILSPARI (sparsentan) in Q4 2023; Total of 1,452 PSFs received in 2023 Company nearing submission of sNDA to convert U.S. accelerated approval of FILSPARI in IgAN to full approval ...
Deric Dube Drug Administration European Union Devices Agency Program Updates Committee For Medicinal Products Human Use
Source: wallstreet-online.de
TN TRB Teacher Recruitment 2024: Registrations for 1768 Posts to Begin Tomorrow at trb.tn.gov.in
A valid Tamil Nadu Teachers Eligibility Test Certificate is required of candidates applying for the position of Secondary Grade Teacher
Tamil Nadu B El Ed Tamil Nadu Teachers Recruitment Board Secondary Grade Teacher Tamil Nadu Teachers Eligibility Test Certificate Secondary Grade
Source: news18.com
How to unlock your inner genius: PAUL MCKENNA explains how to overcome the psychological limitations that are holding you back, supercharge your confidence and achieve success
Paul McKenna reveals how easy it is to find your inner genius, so you can start reaching for a life that is richer, bigger and better than you have ever allowed yourself to imagine.
Source: dailymail.co.uk